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Abstract
Lysosomal storage diseases are the most common cause of neurodegeneration in children. They are characterised at the 
cellular level by the accumulation of storage material within lysosomes. There are very limited therapeutic options, and the 
search for novel therapies has been hampered as few good small animal models are available. Here, we describe the use of 
light sheet microscopy to assess lipid storage in drug and morpholino induced zebrafish models of two diseases of cholesterol 
homeostasis with lysosomal dysfunction: First, Niemann–Pick type C disease (NPC), caused by mutations in the lysosomal 
transmembrane protein NPC1, characterised by intralysosomal accumulation of cholesterol and several other lipids. Sec-
ond, Smith–Lemli–Opitz syndrome (SLOS), caused by mutations in 7-dehydrocholesterol reductase, which catalyses the 
last step of cholesterol biosynthesis and is characterised by intralysosomal accumulation of dietary cholesterol. This is the 
first description of a zebrafish SLOS model. We find that zebrafish accurately model lysosomal storage and disease-specific 
phenotypes in both diseases. Increased cholesterol and ganglioside GM1 were observed in sections taken from NPC model 
fish, and decreased cholesterol in SLOS model fish, but these are of limited value as resolution is poor, and accurate ana-
tomical comparisons difficult. Using light sheet microscopy, we were able to observe lipid changes in much greater detail 
and identified an unexpected accumulation of ganglioside GM1 in SLOS model fish. Our data demonstrate, for the first time 
in zebrafish, the immense potential that light sheet microscopy has in aiding the resolution of studies involving lysosomal 
and lipid disorders.
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Introduction
Lysosomal storage diseases (LSDs) are a group of ~ 70 
inherited metabolic disorders, nearly all of which are char-
acterised by intra-lysosomal accumulation of storage mate-
rial, neurodegeneration and peripheral involvement (Cox 
and Cachón-González 2012). Together, LSDs are the most 
common cause of childhood neurodegeneration often caus-
ing early mortality, but at present with very few therapeutic 
options (Onyenwoke and Brenman 2015). It is, therefore, 
important to understand disease aetiology, especially in vivo, 
to discover new therapeutic targets and develop new treat-
ments for these diseases.
Animal models of LSDs are available across a range of 
species including mouse, rat, dog, cat, pig and zebrafish 
(Bond et al. 2013; Xu et al. 2016). Mice are most commonly 
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used, but are often poor models of disease progression and 
hallmarks, reviewed here (Favret et al. 2020). Increasingly, 
large mammals are used to model LSDs; these models offer 
advantages in translation of effects to humans, particularly 
due to their larger more complex brain (Gurda and Vite 
2019). However, these experiments are both slow and costly 
(Zhang and Peterson 2020).
Zebrafish (Danio rerio) LSD models have risen dramati-
cally over the past 20 years, now with more than 20 different 
LSDs, reviewed here (Zhang and Peterson 2020). Zebrafish 
are extremely useful for therapeutic advancement as they 
provide a model that is cheap, quick to breed and fast to 
develop. Zebrafish lay eggs that are fertilised externally and 
at predictable times of day; they are also particularly ame-
nable to genetic manipulation, e.g. by morpholino, CRISPR-
Cas9 and TALENs (Adamson et al. 2018). Zebrafish share a 
high degree of genetic similarity to humans, with zebrafish 
homologues for 71% of human genes (Howe et al. 2013). 
This is especially evident with regard to disease modelling, 
as 82% of human disease-associated genes have zebrafish 
homologues (Howe et al. 2013). A further growing advan-
tage of zebrafish is their utility in high-throughput drug 
screening and toxicology assays, work that can significantly 
accelerate and reduce the costs of drug discovery (Wiley 
et al. 2017). Finally, a major advantage over larger animals is 
their optical transparency in the larval stages, allowing easy 
visualisation of stains in vivo, without the need for section-
ing (Zhang and Peterson 2020). One possible drawback of 
zebrafish is the lack of effective and accurate antibodies, 
especially for lysosomal proteins.
A key LSD characteristic, alongside expansion of the 
lysosomal system, is the intra-lysosomal accumulation of 
storage materials, primarily lipids. Cholesterol and gly-
cosphingolipids, gangliosides GM1 and GM2, form the 
primary storage material in the LSDs Niemann–Pick type 
C (NPC) and GM1/GM2 gangliosidosis, respectively, but 
have also been found as secondary storage material in 
many other LSDs (Lloyd-Evans and Platt 2010; Walkley 
and Vanier 2009). Considering the widespread presence of 
cholesterol and gangliosides as secondary storage in LSDs, 
it is fortunate that well-characterised probes to image these 
lipids exist (Viljetić et al. 2012; Chisada et al. 2009). These 
include filipin, a blue fluorescent polyene antibiotic that 
selectively binds cholesterol (Schroeder et al. 1971; Kruth 
and Vaughan 1980), and cholera toxin subunit B (CtxB), 
produced by Vibrio cholerae bacteria and that selectively 
binds ganglioside GM1, which is present in zebrafish, as is 
ganglioside GM2 (Holmgren et al. 1973; Saslowsky et al. 
2010; Boutry et al. 2018). These probes are specific and 
have been used extensively in cellular and tissue section 
studies of LSDs, including secondary storage (Arthur et al. 
2011; Walkley et al. 1998) across species (Pagano 2003; 
Blanchette-Mackie et al. 1989).
This study focuses on imaging lipids in zebrafish 
models of two diseases of sterol homeostasis: NPC and 
Smith–Lemli–Opitz syndrome (SLOS). NPC is a multi-
lipid storage disorder, characterised by intra-lysosomal 
accumulation of cholesterol, gangliosides and multiple 
other lipids in most tissues (Lloyd-Evans et al. 2008). It 
is caused by loss of function mutations in the NPC1 gene, 
and patients present with a progressive neurodegenerative 
disease that includes ataxia and hallmarks of dementia 
(Lloyd-Evans and Platt 2010).
Unlike NPC, which is a sterol transport disease, SLOS 
is a sterol biosynthesis disease, caused by loss of function 
mutations in the DHCR7 gene (Waterham et al. 1998). 
SLOS is a developmental disorder; symptoms include 
birth defects such as microcephaly, cleft palate and limb 
anomalies (Kelley and Hennekam 2000). The DHCR7 
gene encodes an ER membrane protein, 3β-hydroxysterol 
Δ7-reductase (DHCR7), that catalyses the last step of 
cholesterol biosynthesis, converting 7-dehydrocholesterol 
(7-DHC) to cholesterol. This leads to reduced endogenous 
cholesterol production and accumulation of 7-DHC in 
cells and tissues which is thought to underlie the develop-
mental defects via alterations to Sonic hedgehog signalling 
(Moebius et al. 1998). A therapeutic approach to increase 
dietary cholesterol has been shown to be ineffective (Tier-
ney et al. 2010), which may be due to the NPC-like lyso-
somal low-density lipoprotein (LDL)-derived cholesterol 
storage reported in SLOS patient cells (Wassif et al. 2002; 
Platt et al. 2014). This would prevent the exit of dietary 
cholesterol from lysosomes and its utilisation by the bio-
synthetic enzymes in the ER. Animal models of SLOS are 
poor; a drug-induced rat model using the DHCR7 inhibi-
tor, AY9944, being amongst the better current options 
(DeBarber et al. 2011). Zebrafish may provide a new tool 
to study this disease and to further study in situ the extent 
of the endo-lysosomal LDL-cholesterol transport defect, 
which could improve therapeutic options for SLOS.
In this paper we highlight the use of light sheet micros-
copy as a more robust and effective method to visualise 
toxin- and fluorescence-based lipid markers for studying 
lipid storage in zebrafish larvae. Owing to the dearth of 
good antibodies available for zebrafish lysosomal proteins, 
we believe that this combination of light sheet imaging 
with lipid markers could widen the use and characterisa-
tion of zebrafish models of LSDs.
Materials and methods
Unless otherwise stated, all reagents were purchased from 
Sigma-Aldrich or ThermoFisher.




This study only used wild-type adults for breeding; all larvae 
were used prior to 5 days post fertilization and were euthan-
ised using tricaine at the end of all experiments. All animal 
experiments were carried out in accordance with EU direc-
tive 2010/63/EU and the UK Animal Welfare Act, 2006.
Husbandry
Wild-type AB/TL zebrafish, sourced from the Division of 
Biosciences, University College London, were housed in a 
multi-rack aquarium system in the School of Biosciences 
aquarium, Cardiff University at 28 °C on a 14 h light, 10 h 
dark cycle. To obtain embryos, pairs of fish were placed in 
breeding tanks overnight, and eggs collected. Embryos were 
separated into experimental groups and maintained at 28 °C 
in E3 medium (5 mM NaCl, 0.17 mM KCl, 0.33 mM  CaCl2, 
0.33 mM  MgSO4, 0.1% methylene blue) in 24-well plates.
Drug treatments
Embryos were incubated in drug treatments (2  μg/ml 
U18666A, 50 or 75 μM AY9944, 75 μM trazodone, 500 μM 
miglustat (Toronto Research Chemicals, North York, Can-
ada)), separately or in combination, from 6 h post-fertili-
sation (hpf), with drug treatments refreshed daily. Control 
fish were raised in E3 medium containing an equivalent 
percentage of sterile anhydrous DMSO, which in no case 
exceeded 0.25%. Drug treatments were diluted from concen-
trated DMSO (U18666A, AY9944 and trazodone) or water 
(miglustat) stocks in E3 medium, with no more than 0.25% 
total DMSO. Dead fish (determined by disintegration or lack 
of heartbeat) were removed daily. No significant toxicity was 
observed in any of the drug treatments.
To generate npc1 and dhcr7 morphant embryos, 3.5 ng 
morpholino (MO) anti-sense oligonucleotides targeting 
the start ATG of npc1, dhcr7 and p53 messenger RNA 
(Gene Tools, Philomath, USA), diluted in Danieau’s solu-
tion (58 mM NaCl, 0.7 mM KCl, 0.4 mM  MgSO4, 0.6 mM 
Ca(NO3)2, 5 mM HEPES, pH 7.6) with 1% phenol red, were 
pressure-injected using a Narishige UM-1PF micromanipu-
lator (Narishige Group Global, London, UK) and Warner 
PLI-10 pico-liter injector (Warner Instruments, Hamden, 
USA) into one- or two-cell stage embryos using a glass 
capillary injection needle. MO sequences: npc1—5′-TGT 
GGT TTC TCC CCA GCA GAA GCA T-3′ (Schwend et  al. 
2011), dhcr7—5′-TCA CCC TGT CAG ATG CCA TCATG-3′, 
p53—5′-GCG CCA TTG CTT TGC AAG AATTG-3’.
Light microscopy
Images were taken using an AmScope stereo dissection 
microscope (AmScope, Irvine, USA) with Watec WAT-
902H monochrome camera (Watec, Yamagata-Ken, Japan) 
and Corel Video Studio 11 image capture software (Corel, 
Ottawa, Canada), and brightness and contrast adjusted using 
Adobe Photoshop CS6 (Adobe, San Jose, USA).
Behavioural analyses
Spontaneous coiling and escape response analyses were car-
ried out, with minor modifications, as described in Wager 
et al. (2016). Briefly:
Spontaneous coiling
Groups of 20 embryonic zebrafish at 24 hpf were arrayed 
in a petri dish containing E3 medium and placed on an 
AmScope stereo dissection microscope. Three-minute 
recordings were taken at 30 frames per second using a Watec 
WAT-902H monochrome camera and Corel Video Studio 11 
image capture software, and coiling events counted manually 
for each embryo.
Escape response
Individual 72 hpf larvae were placed, in a petri dish contain-
ing E3 medium, on an AmScope stereo dissection micro-
scope, with the larva in the centre of the field of view. Fish 
were lightly touched on the tail with a pipette tip until an 
escape response was elicited. Recordings were taken at 30 
frames per second using a Watec WAT-902H monochrome 
camera and Corel Video Studio 11 image capture software. 
Movies were watched in slow motion, and the time (in s) for 
the fish to leave the field of view recorded.
Heart rate
Individual 72 hpf larvae were placed, in a petri dish con-
taining E3 medium, on an AmScope stereo dissection 
microscope, with the larva in the centre of the field of view. 
One-minute recordings were made at 240 frames per second 
using a GoPro Hero 3 camcorder (GoPro, San Mateo, USA). 
Movies were watched in slow motion, and the number of 
heart beats per minute recorded.
Lysotracker green staining
To visualize lysosomes, live 72 hpf zebrafish were stained 
with lysotracker green as described in Wager et al. (2016). 
Briefly, larvae were incubated in 10 μM lysotracker green 
in phosphate-buffered saline (PBS) for 30 min at room 
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temperature in the dark with agitation and washed three 
times for 5 min in PBS. Larvae were lightly anaesthetised 
with tricaine, and images taken with a Zeiss LSM 880 
upright confocal microscope with Airyscan super resolu-
tion detector using the Zen 2 LSM software package (Zeiss, 
Oberkochen, Germany).
Lipid visualization by light sheet microscopy
Filipin staining
Larvae were fixed in 4% paraformaldehyde in PBS, over-
night at 4 °C, and washed three times for 10 min in PBS con-
taining 0.1% Triton X-100 (PBST). Larvae were blocked 
for 1 h in blocking buffer (PBST containing 5% goat serum 
and 1% BSA), and incubated in 187.5 μg/ml filipin, diluted 
in blocking buffer, for 4 h in the dark at room temperature 
with agitation. Larvae were washed a further three times 
for 10 min in PBST, stored at 4 °C in the dark and imaged 
within 1–2 weeks.
CtxB staining
Larvae were fixed in 4% paraformaldehyde in PBS overnight 
at 4 °C and washed three times for 10 min in PBST. Lar-
vae were incubated in blocking buffer for 1 h at room tem-
perature and incubated overnight in 2.5 μg/ml FITC-CtxB, 
diluted in blocking buffer, overnight at 4 °C in the dark with 
agitation. Following three 10-min washes in PBST, stained 
larvae were stored at 4 °C and imaged within 1–2 weeks.
Light sheet imaging
Stained larvae were embedded in low melting point aga-
rose and imaged using a Zeiss Light sheet Z.1 single plane 
illumination microscope, with a single sCMOS PCO.Edge 
camera and Zen Black software. Filipin was imaged using 
the 405 nm laser and 430 nm emission filter, CtxB using 
the 470 nm laser and 520 nm emission filter. Laser power 
was kept as low as possible to avoid bleaching and never 
exceeded 25%. Maximum intensity projection images were 
exported and brightness and contrast adjusted equally for all 
conditions using Adobe Photoshop CS6.
Statistical analysis
All behavioural data were analysed by one-way ANOVA 
with Tukey’s post-hoc correction (normally distributed) or 
Kruskal–Wallis test with Dunn’s post-hoc correction (not 
normally distributed) following determination of normal dis-




Drug or MO treated 96 hpf larvae were fixed overnight in 4% 
paraformaldehyde in PBS at 4 °C. Larvae were washed three 
times in PBS, cryoprotected overnight in PBS containing 
30% sucrose at 4 °C, immersed in TissueTek OCT (Sakura 
Finetek, Tokyo, Japan) and frozen slowly by lowering into 
isopentane cooled with dry ice. Thin (12 μm) sections were 
taken using a Bright 5000 cryostat (Bright Instruments, 
Luton, UK) onto X-tra adhesive slides (Leica Biosystems, 
Milton Keynes, UK), which were air dried and stored at 
− 80 °C until stained.
Filipin staining (cholesterol)
Sections were allowed to defrost to room temperature, 
washed three times for 5 min in PBS containing 0.1% Triton 
X-100 (PBST), and incubated in 187.5 μg/ml filipin, diluted 
in PBST containing 5% foetal bovine serum (FBS) and 1% 
bovine serum albumin (BSA), for 45 min in the dark at room 
temperature. Sections were washed three times for 5 min 
in PBST, coverslipped using fluoroshield, and stored in the 
dark until imaged.
Cholera toxin subunit B (CtxB) staining (ganglioside GM1)
Sections were allowed to defrost to room temperature, 
washed three times for 5 min in PBST, incubated in block-
ing solution (PBST containing 1% BSA) for 30 min at room 
temperature, and incubated in 2.5 μg/ml FITC-CtxB, diluted 
in blocking solution, overnight at 4 °C in the dark. Sections 
were washed three times for 5 min in PBST, coverslipped 
using fluoroshield and stored in the dark until imaged.
Imaging
Sections were imaged using a Zeiss Colibri LED fluores-
cence microscope, Axiocam Mrm monochrome charged cou-
pled device camera and Axiovision 4.8 software. Excitation 
and emission wavelengths were as follows: filipin—380 nm 
excitation, 430 nm emission, FITC-CtxB—470 nm exci-
tation, 520  nm emission. Brightness and contrast were 
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adjusted equally for all conditions using Adobe Photoshop 
CS6.
Lipid dot‑blots
Lipid standards (cholesterol, sphingomyelin, ceramide, 
sphingosine, phosphatidylserine, glucosylceramide, 
lyso-(bis)phosphatidic acid, mixed gangliosides (Sigma-
Aldrich; Larodan, Solna, Sweden; or Avanti Polar Lipids, 
Alabaster, USA)) were dissolved in ethanol or a 1:1 
chloroform:methanol mix at 2 mg/ml. Lipids (2 μl) were 
spotted onto Immobilon-P PVDF membranes and allowed 
to dry. Membranes were incubated in blocking buffer (PBS 
containing 5% goat serum and 1% BSA) for 1 h at room 
temperature, followed by incubation in 187.5 μg/ml filipin, 
diluted in blocking buffer, for 4 h at room temperature, or in 
0.5 μg/ml FITC-CtxB, diluted in blocking buffer, overnight 
at 4 °C. All incubations took place in the dark with agita-
tion. Following three 10-min washes in PBS, membranes 
were viewed using a Biorad EZ gel documentation system 
(Biorad, Hercules, USA) using the UV (filipin) and blue 
(FITC-CtxB) settings. Brightness and contrast were adjusted 
using Adobe Photoshop CS6.
Thin layer chromatography
Total lipids were extracted from 96 hpf wild-type zebrafish 
larvae in 1:2 (v/v) chloroform:methanol, as described (te 
Vruchte et al. 2004). Samples were centrifuged for 5 min 
at 1000 rpm to remove sediment and washed three times by 
phase separation. For each wash, 1 ml chloroform and 1 ml 
PBS were added, samples centrifuged for 5 min at 1000 rpm, 
and the aqueous (upper) phase removed. The final organic 
phase was dried under  N2 and purified lipids resuspended 
in ethanol. Lipids were separated on high-performance thin 
layer silica gel 60 chromatography (HPTLC) plates using 
a 65:25:4 chloroform:methanol:H2O solvent system and 
visualised using p-anisaldehyde as previously described 
(Maue et al. 2012). Lipid standards, from a total porcine 
brain extract, were from Avanti Polar Lipids.
Results and discussion
NPC disease zebrafish model phenotypes
Two separate methods were utilized to induce NPC in 
zebrafish larvae: a known mammalian Npc1 inhibitor, 
U18666A (Lu et al. 2015), or npc1 morpholino. We com-
pared both drug and morpholino models to confirm that the 
morpholino phenotypes are not caused by off-target effects. 
Expression of Npc1 in zebrafish has been demonstrated by 
Tseng et al (2018). Treatment with 2 µg/ml U18666A did not 
cause any gross morphological defects at 48 hpf (Fig. 1a), 
indicating there were no major off-target effects impacting 
on larvae morphology or development.
NPC is characterised by progressive motor defects 
(Vanier et al. 1988), so it was not unexpected to observe 
behavioural changes in both the 2 µg/ml U18666A treated 
and npc1 morphant larvae at 24 hpf (Fig. 1b, c). Rate of 
spontaneous coiling is a measure of neuromuscular devel-
opment at 1–2 days post fertilisation. Treatment with 2 μg/
ml U18666A caused an ~ 1.5-fold reduction in spontaneous 
coiling over 3 min at 24 hpf. This phenotype was confirmed 
in the npc1 morphant, which also caused a spontaneous coil-
ing defect at 24 hpf, with a similar ~ 1.9-fold reduction.
Having confirmed the presence of a disease-specific 
phenotype, we next determined whether lysosomal stor-
age was present at 96 hpf using the live lysosomal marker 
Lysotracker Green. Super resolution confocal microscopy 
staining of lysosomal volume using Lysotracker Green 
showed a fluorescence increase in the eye of live (sedated) 
2  µg/ml U18666A treated fish compared to controls 
(Fig. 1d), indicating the presence of lysosomal storage, also 
reported in Npc1 null zebrafish larvae (Tseng et al. 2018). 
The eye was chosen as this was the only area where clear 
images of lysosomal storage could be generated by confo-
cal microscopy. We confirmed that this increase represented 
lysosomal storage, and not U18666A autofluorescence, by 
coincubation of larvae with both U18666A and the sub-
strate reduction therapy, miglustat. Miglustat (N-butylde-
oxynojirimycin) is an approved NPC therapy that inhibits 
glycosphingolipid biosynthesis (including gangliosides) and 
reduces lysosomal storage in NPC (Zervas et al. 2001b; te 
Vruchte et al. 2004). Co-treatment with 500 μM miglustat 
for 4 days normalised the level of Lysotracker Green staining 
(Fig. 1d). This confirms that the lysosomal expansion is due 
to U18666A inhibition of Npc1, and likely lysosomal lipid 
storage, rather than off-target effects, as have been suggested 
(Wassif et al. 2002; Bae and Paik 1997).
After confirming lysosomal storage, we next identified 
storage products. We did not confirm that this storage is 
lysosomal by co-staining with lysotracker, as lysotracker 
fluorescence is thought to be dependent on protonation, and 
staining is not maintained, or is only present in large orga-
nelles, following fixation, even with Lysotracker Red DND-
99, marketed as aldehyde fixable, making it unsuitable for 
co-staining in fixed tissue (ThermoFisher). Additionally, the 
focus of this study was on the overall lipid burden in these 
diseases, rather than the subcellular localisation. Cholesterol 
is considered by many as the primary storage material in 
NPC, despite indications otherwise (Malathi et al. 2004; 
Lloyd-Evans and Platt 2010; Feldman et al. 2015) and is, 
therefore, an important phenotype to measure in the NPC 
zebrafish models. Using fixed sections (72 hpf), increased 
levels of filipin staining were observed throughout the brain 
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of 2 µg/ml U18666A-treated or npc1 morphant fish com-
pared to controls (Supplemental Figure 1a). The specificity 
of filipin for cholesterol is shown in Supplemental Figure 2a. 
We also used CtxB to detect ganglioside GM1 (specific-
ity shown in Supplemental Figure 2b) in sections of 72 hpf 
larvae. Increased levels of CtxB staining were observed 
throughout the brain of npc1 morphant fish compared to 
controls (Supplemental Figure 1b), indicative of increased 
ganglioside GM1 deposition. This mirrors previous find-
ings that ganglioside GM1 accumulates as secondary stor-
age material in NPC (Lloyd-Evans et al. 2008) and confirms 
ganglioside GM1 storage as a phenotype in the npc1 mor-
pholino model. We, and others, have confirmed the presence 
of gangliosides in zebrafish larvae by HPTLC (Supplemen-
tal Figure 2c) (Saslowsky et al. 2010; Viljetić et al. 2012; 
Chisada et al. 2009). The presence of substantial cholesterol 
and ganglioside GM1 storage (Fig. 4b and Supplemental 
Figure 1a and b) in the NPC model zebrafish also validates 
these models, as these lipids do not accumulate substantially 
together in any other disease.
SLOS zebrafish model phenotypes
Smith–Lemli–Opitz disease (SLOS) phenotypes were 
induced in zebrafish larvae using either the small mol-
ecule inhibitors of mammalian DHCR7, AY9944 or tra-
zodone (DeBarber et al. 2011; Hall et al. 2013), or dhcr7 
morpholino. We did not observe any p53 mediated toxicity 
in dhcr7 morphant larvae, and co-injection with p53 mor-
pholino did not alleviate the dhcr7 morpholino-induced 
phenotypes. We have, therefore, used dhcr7 morpholino 
alone, with wild-type and sham injected controls. No p53 
morpholino control was deemed necessary for Npc1 as no 
p53 mediated toxicity was observed in earlier studies using 
the same morpholino (Schwend et al. 2011).
Neither 75 µM AY9944 nor 75 µM trazodone caused 
pigmentation changes at 72 hpf. However, 75 µM trazo-
done treatment caused a clear distention of the pericardial 
sac, also present, albeit to a much lesser extent, in 75 µM 
AY9944 treated and dhcr7 morphant fish (Fig. 2a). The eye 
area of fish treated with 75 µM trazodone is reduced ~ 1.8-
fold compared to controls, while neither 75 µM AY9944 
treatment nor dhcr7 morpholino had any effect on eye area 
(Fig. 2b). As this phenotype is not replicated by AY9944 
Fig. 1  Identification of NPC phenotypes in a Npc1 inhibitor and npc1 
morpholino zebrafish larvae model. NPC phenotypes were induced 
in the zebrafish larvae using either the Npc1 inhibitor, U18666A 
(2  µg/ml), or npc1 morpholino (npc1 MO) injected at the 1–2 cell 
stage with DMSO and Sham controls as necessary; a Morphology 
of 48 h post fertilisation (hpf) zebrafish by light microscopy. Quan-
titative behavioural analysis of 24 hpf zebrafish measuring number 
of spontaneous coils over 3 min in 2 µg/ml U18666A treated (b) and 
npc1 morphant (c) zebrafish, *p < 0.05, **p < 0.01, ****p < 0.0001, 
Kruskal–Wallis test with Dunn’s post-hoc correction. Representa-
tive images of LysoTracker Green staining of 96 hpf control and 
U18666A treated zebrafish larvae eyes with and without 500  µM 
miglustat co-treatment (d). Scale bars = 280 µm. N = 3–5, with a min-
imum of 10 fish per N 
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treatment, and eye/vision defects are not reported in SLOS 
patients, this change in eye area is unlikely to be SLOS spe-
cific but is more likely an off-target effect of trazodone. This 
is not surprising, as trazodone is known to inhibit multiple 
proteins (Kraus et al. 2007) and causes visual issues and an 
increased risk of eye-related conditions as side effects when 
used as an antidepressant (Pae et al. 2003; Halikas 1995).
As morphological defects were observed in the pericar-
dial sac at 72 hpf, heart rate was investigated. Treatment with 
both 75 µM AY9944 and 75 µM trazodone reduced heart 
rate at 72 hpf (Fig. 2c), by ~ 1.4 and 1.5-fold, respectively, 
Fig. 2  Identification of SLOS phenotypes in Dhcr7 inhibitor and 
dhcr7 morpholino zebrafish larvae models. SLOS phenotypes were 
induced in the zebrafish larvae using either Dhcr7 inhibitors AY9944 
(75  µM) or trazodone (traz, 75  µM), or dhcr7 morpholino (dhcr7 
MO) injected at the 1–2 cell stage with DMSO and Sham controls 
as necessary; a Morphology of 72 hpf zebrafish by light microscopy. 
Arrowheads indicate heart defects.  Quantitative analysis of 72 hpf 
zebrafish by light microscopy; b eye area. Quantitative behavioural 
analysis of 72 hpf inhibitor treated zebrafish; c heart rate over 1 min 
and d escape response time. Quantitative behavioural analysis of 
72 hpf dhcr7 morphant zebrafish; e heart rate over one minute and 
f escape response time. All analysis by Kruskal–Wallis test with 
Dunn’s post-hoc correction (b, c, d) or one-way ANOVA with Tukey 
post-hoc correction (e, f). *p < 0.05, **p < 0.01, ****p < 0.0001. 
Scale bars = 280 µm. N = 3, with a minimum of 3–10 fish per N 
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compared to control. Congenital heart defects are reported 
in about 50% of SLOS patients, supporting the detection 
of heart rate and pericardial sac defects in the model fish 
as SLOS phenotypes (Lin et al. 1997; Digilio et al. 2003). 
As SLOS, like NPC, is characterised by progressive motor 
defects we were not surprised to identify behavioural phe-
notypes in the fish. Escape response time was significantly 
increased in both 75 µM trazodone and 75 µM AY9944 treat-
ments at 72 hpf with respective ~ 24 and 23-fold increases 
compared to control (Fig.  2d). Both the heart rate and 
escape response defects were confirmed as SLOS specific 
phenotypes, rather than off-target effects of the drugs, using 
dhcr7 morpholino. The dhcr7 morpholino caused a signifi-
cant ~ 1.1-fold decrease in heart rate (Fig. 2e) and fourfold 
increase in escape response time (Fig. 2f) in 72 hpf larvae.
Having confirmed the presence of disease-specific behav-
ioural phenotypes, we next determined whether cholesterol 
biosynthesis and levels were indeed defective. Filipin stain-
ing of 75 µM AY9944 treated zebrafish sections, fixed at 
72 hpf, was reduced compared to controls (Supplemental 
Figure 1c), indicative of a cholesterol biosynthetic defect, as 
observed in other SLOS models and patients (Xu et al. 2011; 
Marcos et al. 2007; Porter 2008). Despite a clear reduction 
in filipin staining, this change is made more difficult to 
observe by the quality of the fish sections.
From our data it is clear that classical cryo-sectioning is 
of limited value for studying lipid distribution in zebrafish 
embryos. This is particularly evident when attempting to 
compare staining intensity in brain areas of different fish that 
are not always perfectly matched. When considered in con-
junction with the potential for artefactual changes caused by 
mechanical tissue manipulation (Griffiths et al. 1993; Taka-
tori and Fujimoto 2015), it is clear that a different approach 
may be required. These difficulties may explain the relative 
absence of fluorescent lipid measurements in LSD zebrafish 
models. One solution may be the use of light sheet micros-
copy which allows for wholemount imaging of zebrafish lar-
vae, with minimal manipulation (Icha et al. 2016). The opti-
cal transparency of the zebrafish allows detection of stained 
brain regions by this method with detail that would not often 
be possible in cryo-sections. We, therefore, tested whether 
light sheet microscopy of 96 hpf whole-mount zebrafish lar-
vae could produce clearer, more detailed images of the lipid 
changes induced by these treatments. A particular strength 
of light sheet microscopy is that it allows the generation of 
deconvolved images from multiple planes with much greater 
penetration than confocal microscopy, and without the inter-
ference from incident light found in wholemount widefield 
fluorescence images. This allows assessment of changes in 
lipid levels in zebrafish organs without any loss of infor-
mation caused by optical sectioning, and gives the clearest 
indication of the lipid burden of the whole organism, which 
we address in the next sections.
Light sheet imaging of filipin
Filipin staining in the SLOS model fish confirmed a reduc-
tion in overall staining, indicating a reduced level of choles-
terol, in both dhcr7 morphant and 75 µM AY9944 treated 
fish compared to control (Fig. 3a), confirming the reduced 
cholesterol levels observed in cryosections of AY9944 
treated fish (Supplemental Figure 1c). However, there is 
considerably more clarity in these light sheet images and 
considerably improved structural integrity. SLOS larvae 
(morphant and AY9944-treated) were imaged in lateral and 
dorsal orientations. The lateral orientation demonstrates that 
treatment with 75 μM AY9944 led to the greatest reduc-
tion in filipin staining. This is consistent with the defects in 
heart rate and escape response identified in Fig. 2. We do 
not believe that these differences are due to off-target effects 
of AY9944, as the difference is only in phenotype sever-
ity: no additional abnormalities were detected in AY9944 
treated fish. We propose that the differences are due to potent 
inhibitory effects of AY9944 against Dhcr7  [IC50 13 nM for 
human DHCR7 (Moebius et al. 1998)] and a milder effect 
of the morpholino. This may be due to the presence of a 
putative dhcr7 paralogue, a9ult1, also known as si:ch1073-
429i10.1, identified by the Zebrafish Mutation Project (Ket-
tleborough et al. 2013), which is not targeted by our dhcr7 
morpholino but may be inhibited by AY9944.
In comparison, the dorsal orientation gives a clear view of 
staining within the brain in control fish. Cholesterol is pre-
sent within the olfactory bulb, telencephalon, optic tectum, 
and cerebellum (see Supplemental Figure 3 for zebrafish 
brain regions). These brain regions can also be identified in 
the morpholino and AY9944 treated fish; however, staining 
is reduced in all, with greatly reduced filipin staining in the 
optic tectum. This suggests that no particular area of the 
brain is more affected than any other by the loss of Dhcr7 
activity and that dhcr7 is expressed across all zebrafish brain 
areas. This is not surprising, as cholesterol is a fundamen-
tal component of all cellular membranes, where it regulates 
membrane fluidity and the organisation of membrane micro-
domains (Lloyd-Evans and Waller-Evans 2020). A reduc-
tion in cholesterol, and presumptive accumulation of the 
toxic precursor, 7-DHC (Wassif et al. 1998), throughout the 
brain is also consistent with the pleiotropic developmen-
tal defects and global developmental delay seen in SLOS 
patients (Nowaczyk and Wassif 1993–2000).
Comparatively, filipin staining in NPC model fish was 
increased overall compared to control (Fig. 3b), indicative 
of cholesterol storage, and confirming the elevated staining 
seen in the NPC model fish sections (Supplemental Fig-
ure 1a). However, with light sheet imaging, this storage can 
be observed with much greater clarity and can be localised 
to particular brain areas. It should be noted that the level 
of staining in these control zebrafish appears lower than in 
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control SLOS fish (Fig. 3a). This is a result of alterations 
in the imaging parameters to allow for the visualization of 
both reduced and increased cholesterol levels in the SLOS 
and NPC model zebrafish, respectively, relative to matched 
controls, without any excess saturation. As the control fish 
appear dimmer, brain regions are less easily identified. 
However, in the npc1 morphant, a clear increase in staining 
can be seen in the olfactory bulb, telencephalon and optic 
tectum. The cerebellum and hindbrain, not visible in the 
control, are also strongly stained. While 2 µg/ml U18666A 
causes a less pronounced increase than the morphant, the 
olfactory bulb, telencephalon, cerebellum and, to an even 
greater degree, the optic tectum, all have strongly increased 
filipin staining compared to the control. Morphant fish had 
the brightest filipin staining, suggesting stronger loss of 
Npc1 function following morpholino knock down of npc1 
than with U18666A. This could be explained by inhibition 
of cholesterol biosynthesis or potential up-regulation of 
Npc1 expression in the 2 µg/ml U18666A treated fish, as has 
been suggested to happen in mammals (Bae and Paik 1997; 
Watari et al. 2000). Equally, this could reflect an impairment 
of U18666A transport across the chorion. As is the case 
with other NPC animal models, and similar to SLOS, this 
indicates that multiple brain regions are impaired in the NPC 
model zebrafish. Again, this is unsurprising, as the NPC1 
protein is ubiquitously expressed in mammals (Ramirez 
et al. 2011). The finding of high levels of cholesterol storage 
in the cerebellum is another indicator that both the U18666A 
and npc1 morpholino models accurately replicate NPC.
Light sheet imaging of CtxB
Light sheet microscopy clearly demonstrated the expected 
changes in cholesterol levels in the SLOS and NPC model 
zebrafish. We, therefore, determined whether light sheet 
imaging could be used to study changes in the levels of gan-
glioside GM1, a common secondary storage molecule in 
LSDs, using CtxB.
We first examined the drug-induced SLOS model 
zebrafish and observed an unexpected increase in CtxB 
staining at 96 hpf compared to controls (Fig. 4a), with the 
increase visibly greatest in the 75 µM AY9944 treated fish. 
Although this was not tested in dhcr7 morphant zebrafish, 
we are confident that this increase is a real SLOS pheno-
type, as it is present in both drug treatments, and elevated 
ganglioside levels are found in the widely used AY9944 rat 
Fig. 3  Cholesterol is reduced 
in SLOS model zebrafish 
and increased in NPC model 
zebrafish. Representative 
images of filipin staining of 96 
hpf zebrafish to observe cho-
lesterol distribution; a Filipin 
staining of SLOS zebrafish 
models induced using either 
the Dhcr7 inhibitor AY9944 
(75 µM) or dhcr7 morpholino 
(dhcr7 MO) injected at the 
1–2 cell stage. Images of the 
zebrafish head and upper body 
from a lateral view (left) or 
dorsal view (right); b Filipin 
staining of NPC zebrafish mod-
els induced using either npc1 
morpholino (npc1 MO) injected 
at the 1–2 cell stage or the Npc1 
inhibitor, U18666A (2 µg/ml). 
Images of the zebrafish head 
from a dorsal viewpoint. Brain 
areas are indicated by coloured 
bars above images. Scale 
bars = 280 µm. N = 3, with a 
minimum of ten fish per N 
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SLOS model (data not shown) (DeBarber et al. 2011). Most 
of the increases in the 75 µM AY9944 treated fish were in the 
brain and lower jaw regions as seen from the lateral orienta-
tion, with increases seen from the dorsal viewpoint in the 
olfactory bulb, optic tectum, and hindbrain, seen from both 
orientations. It is not surprising to see changes in ganglio-
side GM1 concentrations in the lower jaw of the zebrafish as 
facial developmental abnormalities are common in SLOS; in 
particular, micrognathia (small lower jaw) has been observed 
in more than 2/3rds of SLOS patients, indicating that this 
structure is particularly susceptible to loss of DHCR7 activ-
ity (Scalco et al. 2006). In the 75 µM trazodone treated fish 
we observed increased staining in the olfactory bulb and 
hindbrain, and also in the eye, which could be related to 
the trazodone-induced retinal area defect (Fig. 2b). The 
increases observed in ganglioside GM1 are likely due to 
a change in metabolism: reduced cholesterol levels could 
cause increased membrane fluidity, necessitating the inser-
tion of additional lipid ordered domains which are ganglio-
side dense (Tulenko et al. 2006; Cecchi et al. 2009).
Similarly, CtxB staining was also increased, as expected, 
in the both the morphant and 2 µg/ml U18666A NPC model 
fish compared to the control, confirming the secondary 
storage of ganglioside GM1 in NPC fish (Fig. 4b), also 
observed in the NPC mouse and cat models (Vite et al. 
2015; Zervas et al. 2001a). However, the pattern of increased 
staining in NPC models compared to controls is clearly very 
different to that in the SLOS models. The increased CtxB 
staining in the npc1 morphant is localised around the olfac-
tory bulb, optic tectum and in the cerebellum. Treatment 
with 2 µg/ml U18666A induced a more general increase in 
CtxB staining, similar to the global increase in filipin stain-
ing observed in these fish. The regions with the greatest 
accumulation of ganglioside GM1 are the olfactory bulb, 
optic tectum and cerebellum, the same areas that store in 
the morphant fish. This suggests that these areas are more 
severely affected by the loss of Npc1 activity, possibly 
because of higher levels of Npc1 expression, resulting in 
a higher storage burden. As with the filipin staining, it was 
impossible to discern this level of detail from CtxB stained 
cryosections, which merely indicated a general increase in 
ganglioside GM1 levels.
The patterns of cholesterol and ganglioside GM1 storage 
in the NPC model fish are not identical, with the filipin stain-
ing indicating a much more general increase in cholesterol 
storage throughout the fish. However, both stains indicate 
Fig. 4  Ganglioside GM1 is 
increased in both SLOS and 
NPC zebrafish models. Rep-
resentative images of cholera 
toxin subunit B (CtxB) staining 
of 96 hpf zebrafish to observe 
ganglioside GM1 distribu-
tion; a CtxB staining of SLOS 
zebrafish models induced 
using the Dhcr7 inhibitors 
AY9944 (75 µM) or trazodone 
(traz) (75 µM). Images of the 
zebrafish head from a lateral 
view (left) or dorsal view 
(right); b CtxB staining of NPC 
zebrafish models induced using 
either npc1 morpholino (npc1 
MO) injected at the 1–2 cell 
stage or the Npc1 inhibitor, 
U18666A (2 µg/ml). Images 
of the zebrafish head from a 
dorsal viewpoint. Brain areas 
are indicated by coloured bars 
above images. Please note that 
the NPC images were taken 
using a separate Z.1 light sheet 
microscope that had been set 
up slightly differently. Scale 
bars = 280 µm. N = 3, with a 
minimum of ten fish per N 
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that the most severe storage is found in the olfactory bulb, 
optic tectum, and cerebellum. While this study focuses on 
lipid accumulation at the organ level, these staining patterns 
are consistent with reports in mouse and cat models of NPC, 
where filipin and anti-ganglioside antibodies localise both 
lipids to the same neurons in NPC mice (Zervas et al. 2001a; 
Vite et al. 2015) and in patient cells (Bergamin et al. 2013). 
However, the pattern of ganglioside GM1 accumulation is 
more spatially restricted than that of cholesterol accumula-
tion. This suggests that the accumulation of cholesterol in 
NPC model fish is not entirely dependent on the accumula-
tion of gangliosides, as has been suggested in mice (Gondré-
Lewis et al. 2003).
Conclusion
To make the most of this type of imaging it would be ideal 
to co-stain the fish with markers for several lipids at once, 
as there are many available lipid stains that work well in 
zebrafish and are easily detectible by light sheet microscopy, 
detailed in Table 1. The use of several markers would allow 
comparison of localisations within a single fish, from mul-
tiple angles, which could provide valuable detailed informa-
tion about lipid storage in many LSDs. Another important 
use of light sheet microscopy would be combining mutant 
fish with morpholinos against sphingolipid biosynthetic 
genes to investigate which pathways contribute to lipid stor-
age and are, therefore, potential drug targets. This would 
provide a much faster method for uncovering mechanistic 
information about disease pathogenesis and identifying 
novel drug targets, as data could be generated within 5 days 
using a zebrafish model, compared to the several months 
needed to generate and obtain the same information in 
mouse models.
The use of zebrafish models, especially in rare disease 
research, is dramatically increasing due to their numerous 
advantages over more traditional model organisms. Zebrafish 
often make very good LSD models, for example in CLN3 
and Gaucher diseases where zebrafish models most closely 
recapitulate the human disease (Wager et al. 2016; Keatinge 
et al. 2015). We hope that the use of light sheet microscopy 
in zebrafish models of rare disease will allow more rapid 
progression of the field, yielding invaluable breakthroughs 
in our understanding of these diseases.
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Table 1  Lipid probes used in fluorescence and confocal imaging in zebrafish
HC histochemistry, IHC immunohistochemistry, GSLs glycosphingolipids
Lipid Probe Conditions References
Sphingolipids
 Glycosphingolipids Periodic acid Schiff (for polysaccharides) Fixed, HC Kim et al. (2013)
 Ganglioside GM1 Antibody Fixed IHC Viljetić et al. (2012)
 Ganglioside GM1 Cholera toxin B Fixed, IHC Runft et al. (2014)
 Ganglioside GM2 Antibody Fixed, IHC Boutry et al. (2018)
 Ganglioside GM4 Antibody Chisada et al. (2009)
 Sulfatide Toluidine blue for sulphated GSLs (also polysac-
charides and nucleic acid
Fixed, HC Kim et al. (2013)
Other lipids
 Cholesterol Filipin Fixed, HC Kim et al. (2013, Louwette et al. (2013)
 Neutral lipids Oil Red O Fixed, HC Kadereit et al. (2008). Kim et al. 
(2013), Raldúa et al. (2008)
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